Home › Cirrhosis
Cirrhosis clinical trials recruiting in the U.S.
37 studies for Cirrhosis are recruiting participants at sites across the United States.
Cirrhosis is caused when scar tissue replaces healthy tissue in the liver because of chronic injury. Learn how cirrhosis is diagnosed and treated.
Cities with the most studies
- Boston, MA9 studies
- Cleveland, OH9 studies
- Dallas, TX9 studies
- Houston, TX8 studies
- Miami, FL7 studies
- San Antonio, TX7 studies
- Los Angeles, CA6 studies
- New York City, NY5 studies
- Rochester, MN4 studies
- San Diego, CA4 studies
- Durham, NC4 studies
- Indianapolis, IN4 studies
- Chicago, IL4 studies
- Nashville, TN4 studies
- New Orleans, LA4 studies
- Round Rock, TX4 studies
- Baltimore, MD4 studies
- Richmond, VA3 studies
- Minneapolis, MN3 studies
- Philadelphia, PA3 studies
- Austin, TX3 studies
- Doral, FL3 studies
- Arlington, TX3 studies
- Tucson, AZ3 studies
- Chandler, AZ3 studies
- Columbus, OH3 studies
- Tampa, FL3 studies
By state
- Arizona6 studies
- California11 studies
- Colorado3 studies
- Florida9 studies
- Georgia3 studies
- Illinois4 studies
- Indiana5 studies
- Kansas3 studies
- Louisiana4 studies
- Maryland4 studies
- Massachusetts9 studies
- Michigan3 studies
- Minnesota7 studies
- Missouri3 studies
- New York6 studies
- North Carolina6 studies
- Ohio12 studies
- Pennsylvania6 studies
- Tennessee6 studies
- Texas15 studies
- Virginia3 studies
Recently updated studies
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Nov 12, 2026 · NCT07325526Endoscopic Ultrasound Shear Wave Elastography Study
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT06592820Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Nov 9, 2026 · NCT07631637Trial to Evaluate ALN-CIDEB in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Nov 5, 2026 · NCT07854782High Dose Albumin in Refractory Ascites
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT05867602Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07610837LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT06632444Evaluation of Non-Invasive Tests for Metabolic Liver Disease
RecruitingObservational study
Ages 18 to 75 · All sexes · Updated Oct 26, 2026 · NCT07122700Magnetic Resonance Elastography as a Method to Estimate Stiffness of Soft Tissues
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 21, 2026 · NCT01757730Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis
RecruitingObservational study
Ages 18 to 99 · All sexes · Updated Oct 14, 2026 · NCT06265272HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
Recruiting
Ages 18 and older · All sexes · Updated Oct 7, 2026 · NCT05205954Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 7, 2026 · NCT05028829Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 28, 2026 · NCT05832229HMB Enriched Amino Acids to Reverse Muscle Loss in Cirrhosis
Recruiting
Ages 21 to 65 · All sexes · Updated Sep 28, 2026 · NCT05166499Molecular Mechanism of Exercise in Cirrhosis
Recruiting
Ages 21 to 65 · All sexes · Updated Sep 28, 2026 · NCT05982769National Liver Cancer Screening Trial
RecruitingPhase 4
Ages 18 to 85 · All sexes · Updated Sep 25, 2026 · NCT06084234Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
RecruitingHealthy volunteers welcome
Ages 18 to 70 · All sexes · Updated Aug 21, 2026 · NCT03208868Fibrosis Lessens After Metabolic Surgery
RecruitingPhase 4Healthy volunteers welcome
Ages 18 to 75 · All sexes · Updated Jul 31, 2026 · NCT06374875Measuring Patient Reported Needs in Outpatient Liver Disease Management
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 29, 2026 · NCT07191886Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT05181826Multi-analyte Blood Test Clinical Trial
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT05199259Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
Recruiting
Ages 18 and older · All sexes · Updated Jun 25, 2026 · NCT06138821Digoxin In NASH (CODIN)
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated May 26, 2026 · NCT06588699Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver Transplant
RecruitingObservational study
Ages 18 to 75 · All sexes · Updated May 7, 2026 · NCT06950788COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 5, 2026 · NCT05692024From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.